The patient should not take APO-ATOMOXETINE if he/she: is taking or has recently taken an antidepressant medicine known as a monoamine oxidase inhibitor (MAOI), including phenelzine sulfate and tranylcypromine sulfate; has narrow angle glaucoma, an eye disease; is allergic to atomoxetine or any other ingredient of APO-ATOMOXETINE; has symptomatic cardiovascular disease; has moderate to severe high blood pressure; has advanced arteriosclerosis (hardened arteries); has uncontrolled hyperthyroidism (an overactive thyroid gland).
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Sign Out
